Parfrey LW, Walters WA, Knight R (2011). Microbial eukaryotes in the human microbiome: Ecology, evolution, and future directions. Front Cell Infect Microbiol 2: 1–6. doi: 10.3389/fmicb.2011.00153
[2]
Bogitsh BJ, Carter CE, Oeltmann TN (2012). Human Parasitology, 4the edition. Elsevier Academic Press, San Diego, USA; 430 pp.
[3]
Andersen LO, Nielsen HV, Stensvold CR (2013). Waiting for the human intestinal eukaryotome. ISME J 7: 1253–1255. doi: 10.1038/ismej.2013.21. pmid:23407309
[4]
Lewthwaite P, Gill GV, Hart CA, Beeching NJ (2005). Gastrointestinal parasites in the immunocopromised persons. Curr Opin Infect Dis 18: 427–35. pmid:16148530
[5]
Luke？ J, Kuchta R, Scholz T, Pomajbíková K (2014) (Self-) infections with parasites: re-interpretation for the present. Trends Parasitol 30: 377–385. doi: 10.1016/j.pt.2014.06.005. pmid:25033775
[6]
Scanlan PD, Stensvold CR, Rajilic-Stojanovic M, Heilig HGHJ, De Vos WM, O’Toole PW, Cotter PD (2014) The microbial eukaryote Blastocystis is a prevalent and diverse member of the healthy human gut microbiota. FEMS Microb Lett 90: 326–330. doi: 10.1111/1574-6941.12396
[7]
Parfrey LW, Walters WA, Lauber CL, Clemente JC, Berg-Lyons D, Teiling C, Kodira C, Mohiuddin M, Brunelle J, Driscoll M, Fierer N, Gilbert JA, Knight R (2014). Communities of microbial eukaryotes in the mammalian gut within the context of environmental eukaryotic diversity. Front Microbiol 5: 298. doi: 10.3389/fmicb.2014.00298. pmid:24995004
[8]
Rossen NG, Bart A, Verhaar N, van Nood E, Kootte R, de Groot PF, D'Haens GR, Ponsioen CY, van Gool T (2015). Low prevalence of Blastocystis sp. In active ulcerative colitis patients. Eur J Clin Microbiol Infect Dis 34: 1039–1044. doi: 10.1007/s10096-015-2312-2. pmid:25680316
[9]
Barratt JLN, Harkness J, Marriott D, Ellis JT, Stark D (2011). A review of Dientamoeba fragilis carriage in humans: Several reasons why this organism should be considered in the diagnosis of gastrointestinal illness. Gut Microbes 2: 3–12. doi: 10.4161/gmic.2.1.14755. pmid:21637013
[10]
Velasquez-Manoff M (2012). An epidemic of absence. New York, Scribner.
[11]
Rook GAW, Raison CL, Lowry CA (2014). Microbial ‘old friends’, immunoregulation and socioeconomic status. Clin Exp Immunol 177: 1–12. doi: 10.1111/cei.12269. pmid:24401109
[12]
Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R (2012). Diversity, stability and resilience of the human gut microbiota. Nature 489: 220–230. doi: 10.1038/nature11550. pmid:22972295
[13]
Pliekatt JL, Deenonpoe R, Mulvenna JP, Krause L, Sripa B, Bethony JM, Brindley P (2013) Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome. FASEB J 27: 4572–4584. doi: 10.1096/fj.13-232751. pmid:23925654
[14]
Morton ER, Lynch J, Froment A, Lafosse S, Heyer E, Przeworski M, Blekhman R, Segurel L (2015) Variation in rural African gut microbiomes is strongly shaped by parasitism and diet. . Accessed 17 July 2015.
[15]
Cooper P, Walker AW, Reyes J, Chico M, Salter SJ, Vaca M, Parkhill J (2013) Patent human infections with the whipworm, Trichuris trichiura, are not associated with alterations in the faecal microbiota. PLoS One 8: e76573. doi: 10.1371/journal.pone.0076573. pmid:24124574
[16]
Cantacessi C, Giacomin P, Croese J, Zakrzewski M, Sotillo J, McCann L, Nolan MJ, Mitreva M, Krause L, Loukas A (2014). Impact of experimental hookworm infection on the human gut microbiota. J Infect Dis 210: 1431–1434. doi: 10.1093/infdis/jiu256. pmid:24795483
[17]
Schnorr SL, Candela M, Rampelli S, Centanni M, Consolandi C, Basaglia G, Turroni S, Biagi E, Peano C, Severgnini M, Fiori J, Gotti R, De Bellis G, Luiselli D, Brigidi P, Mabulla A, Marlowe F, Henry AG, Crittenden AN (2014). Gut microbiome of the Hadza hunter-gatherers. Nat Commun 5: 3654. doi: 10.1038/ncomms4654. pmid:24736369
[18]
Committee (1998). Dientamoeba fragilis: A harmless commensal or a mild pathogen? Paediatr Child Health 3: 81–82. pmid:20401204
[19]
Coyle CM, Varughese J, Weiss LM, Tanowitz HB (2012) Blastocystis: to treat or not to treat. Clin Infect Dis 54: 105–110. doi: 10.1093/cid/cir810. pmid:22075794
[20]
Wiria AE, Djuardi Y, Supali T, Sartono E, Yazdanbakhsh M (2012). Helminth infection in populations undergoing epidemiological transition: A friend or foe? Semin Immunopathol 34: 889–901. doi: 10.1007/s00281-012-0358-0. pmid:23129304
[21]
Elliott DE, Weinstock JV (2012). Where are we on worms? Curr Opin Gastroenterol 28: 551–556. doi: 10.1097/MOG.0b013e3283572f73. pmid:23079675
[22]
Clemente JC, Ursell LK, Parfrey LW, Knight R (2012). The impact of the gut microbiota on human health: An integrative view. Cell 148: 1258–1270. doi: 10.1016/j.cell.2012.01.035. pmid:22424233
[23]
Leung JM, Davenport M, Wolff MJ, Wiens KE, Abidi WM, Poles MA, Cho I, Ullman T, Mayer L, Loke P (2014). Il-22-producing cd4+ cells are depleted in actively inflamed colitis tissue. Mucosal Immunol 7, 124–133. doi: 10.1038/mi.2013.31. pmid:23695510
[24]
Sommer F., Backhed F. (2013) The gut microbiota—masters of host development and physiology. Nat Rev Microbiol 11: 227–38. doi: 10.1038/nrmicro2974. pmid:23435359
[25]
Scanlan PD, Stensvold CR (2013). Blastocystis: getting to grips with guileful guest. Trends Parasitol 29: 523–529. doi: 10.1016/j.pt.2013.08.006. pmid:24080063
[26]
Graham AL, Hayward AD, Watt KA, Pilkington JG, Pemberton JM, Nussey DH (2010) Fitness correlates of heritable variation in antibody responsiveness in a wild mammal. Science 330: 662–665. doi: 10.1126/science.1194878. pmid:21030656
